Agenus

About Agenus

Agenus Inc. is a clinical-stage biotechnology company that discovers, manufactures, and develops immuno-oncology products. The company focuses on therapies that activate the immune system to treat cancer and infections, utilizing checkpoint antibodies, vaccine adjuvants, and other synergistic agents. Agenus develops a broad portfolio of antibody therapeutics, adjuvants, and vaccines, and operates globally with partnerships to accelerate development and commercialization of its pipeline.